Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-02-02 to 2024-05-22
Current total value of award: $41.05
Description: 8509677116!OMEPRAZOLE EXTENDED